Neurotoxicity of cobalt

Cobalt exerts well-known and documented toxic effects on the thyroid, heart and the haematopoietic system, in addition to the occupational lung disease, allergic manifestations and a probably carcinogenic action. Cobalt neurotoxicity is reported in isolated cases, and it has never been systematically treated. Bilateral optic atrophy and retinopathy, bilateral nerve deafness and sensory-motor polyneuropathy have been described long ago as a result of chronic occupational exposure to cobal powder or during long-term treatment of anaemia with cobalt chloride. Recently, some patients with high levels of cobalt released from metal prosthesis have been referred as presenting with tinnitus, deafness, vertigo, visual changes, optic atrophy, tremor and peripheral neuropathy. The aim of this work is to group these cases and to identify a possible mechanism of cobalt neurotoxicity, focusing on hypothetic individual susceptibility such as altered metal-binding proteins, altered transport processes in target cells or polymorphic variation of genetic background.

[1]  S. Yang,et al.  Cobalt chloride-induced apoptosis and extracellular signal-regulated protein kinase 1/2 activation in rat C6 glioma cells. , 2004, Journal of biochemistry and molecular biology.

[2]  P. Apostoli,et al.  Loss of sight and sound. Could it be the hip? , 2009, The Lancet.

[3]  P. Barbieri,et al.  In vitro percutaneous absorption of cobalt , 2004, International archives of occupational and environmental health.

[4]  B. Morrey Arthroprosthetic Cobaltism: Neurological and Cardiac Manifestations in Two Patients with Metal-on-Metal Arthroplasty: A Case Report , 2011 .

[5]  D. Bar-Or,et al.  A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. , 2000, The Journal of emergency medicine.

[6]  D. Lison,et al.  Health risks associated with cobalt exposure--an overview. , 1994, The Science of the total environment.

[7]  T. Vail,et al.  Changes in Whole Blood Metal Ion Levels following Resurfacing: Serial Measurements in a Multi-Centre Study , 2009, Hip international : the journal of clinical and experimental research on hip pathology and therapy.

[8]  D. Fox,et al.  Developmental lead exposure inhibits adult rat retinal, but not kidney, Na+,K(+)-ATPase. , 1991, Toxicology and applied pharmacology.

[9]  G. Semenza,et al.  Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. , 1999, Annual review of cell and developmental biology.

[10]  G. Semenza,et al.  HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. , 2006, Cell metabolism.

[11]  T Khan,et al.  Metal ion levels after metal-on-metal Ring total hip replacement: a 30-year follow-up study. , 2007, The Journal of bone and joint surgery. British volume.

[12]  B. Sarkar,et al.  Heavy Metals in the Environment , 2002 .

[13]  D. Zukor,et al.  Metal ion levels in the blood of patients after hip resurfacing: a comparison between twenty-eight and thirty-six-millimeter-head metal-on-metal prostheses. , 2008, The Journal of bone and joint surgery. American volume.

[14]  Pat Campbell,et al.  Serum levels of cobalt and chromium in patients with Sikomet metal–metal total hip replacements , 2005, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[15]  A. Disch,et al.  Massive metallosis after revision of a fractured ceramic head onto a metal head , 2003, Archives of Orthopaedic and Trauma Surgery.

[16]  K. Webster,et al.  A unique pathway of cardiac myocyte death caused by hypoxia–acidosis , 2004, Journal of Experimental Biology.

[17]  P. Spinelli,et al.  Absorption and excretion of cobalt in the hard metal industry. , 1994, The Science of the total environment.

[18]  B. Fredholm,et al.  Toxic effects of cobalt in primary cultures of mouse astrocytes. Similarities with hypoxia and role of HIF-1alpha. , 2007, Biochemical pharmacology.

[19]  L. Sanzén,et al.  Catastrophic failure due to aggressive metallosis 4 years after hip resurfacing in a woman in her forties—a case report , 2010, Acta orthopaedica.

[20]  Kenneth J. Smith,et al.  Demyelination: The Role of Reactive Oxygen and Nitrogen Species , 1999, Brain pathology.

[21]  M. Oldenburg,et al.  Severe cobalt intoxication due to prosthesis wear in repeated total hip arthroplasty. , 2009, The Journal of arthroplasty.

[22]  P. Apostoli,et al.  Biological monitoring of tungsten (and cobalt) in workers of a hard metal alloy industry , 2010, International archives of occupational and environmental health.

[23]  W. J. Clerici,et al.  Direct effects of reactive oxygen species on cochlear outer hair cell shape in vitro , 1995, Hearing Research.

[24]  G. Piolatto,et al.  Blind and deaf after total hip replacement? , 2009, The Lancet.

[25]  P. Campbell,et al.  Metal-on-metal hybrid surface arthroplasty: two to six-year follow-up study. , 2004, The Journal of bone and joint surgery. American volume.

[26]  P J Sadler,et al.  Transferrin as a metal ion mediator. , 1999, Chemical reviews.

[27]  C. Ranawat,et al.  Serum metal levels and bearing surfaces in total hip arthroplasty. , 2006, The Journal of arthroplasty.

[28]  P. Gros,et al.  Nramp 2 (DCT1/DMT1) Expressed at the Plasma Membrane Transports Iron and Other Divalent Cations into a Calcein-accessible Cytoplasmic Pool* , 2000, The Journal of Biological Chemistry.

[29]  E. Rubel,et al.  Reactive oxygen species in chick hair cells after gentamicin exposure in vitro , 1997, Hearing Research.

[30]  S. Porru,et al.  Urinary cobalt excretion in short time occupational exposure to cobalt powders. , 1994, The Science of the total environment.

[31]  J. M. Christensen,et al.  A 1982-1992 surveillance programme on Danish pottery painters. Biological levels and health effects following exposure to soluble or insoluble cobalt compounds in cobalt blue dyes. , 1994, The Science of the total environment.

[32]  Klaus V. Toyka,et al.  Inflammatory mediators in demyelinating disorders of the CNS and PNS , 1992, Journal of Neuroimmunology.

[33]  R. Peach,et al.  Rapid detection and initial characterization of genetic variants of human serum albumin. , 1991, Clinical Chemistry.

[34]  G. Lippi,et al.  High-workload endurance training may increase serum ischemia-modified albumin concentrations , 2005, Clinical chemistry and laboratory medicine.

[35]  D. Chappard,et al.  Migration of metal and polyethylene particles from articular prostheses may generate lymphadenopathy with histiocytosis. , 1996, Journal of biomedical materials research.

[36]  H. Rho,et al.  Transcriptional repression of the human p53 gene by cobalt chloride mimicking hypoxia , 2001, FEBS letters.

[37]  Mohan K. Wali,et al.  Heavy Metals in the Environment , 1983 .

[38]  T. Smith Human serum transferrin cobalt complex: stability and cellular uptake of cobalt. , 2005, Bioorganic & medicinal chemistry.

[39]  E. Englander,et al.  Mitochondrial DNA damage and a hypoxic response are induced by CoCl(2) in rat neuronal PC12 cells. , 2000, Nucleic acids research.

[40]  D. Whitman,et al.  Activity and passive-avoidance learning in cobalt-injected rats. , 1998, The International journal of neuroscience.

[41]  Caterina Virginio,et al.  Effects of divalent cations, protons and calmidazolium at the rat P2X7 receptor , 1997, Neuropharmacology.

[42]  C. Lanvers-Kaminsky,et al.  Sequence variations of mitochondrial DNA and individual sensitivity to the ototoxic effect of cisplatin. , 2003, Anticancer research.

[43]  D. Lison,et al.  Epidemiological survey of workers exposed to cobalt oxides, cobalt salts, and cobalt metal. , 1993, British journal of industrial medicine.

[44]  D. Lison,et al.  Biological monitoring of workers exposed to cobalt metal, salt, oxides, and hard metal dust. , 1994, Occupational and environmental medicine.

[45]  N. Handly Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction , 2004 .

[46]  B. Michalke,et al.  Comparison between exhaled breath condensate analysis as a marker for cobalt and tungsten exposure and biomonitoring in workers of a hard metal alloy processing plant , 2009, International archives of occupational and environmental health.

[47]  A. Licht,et al.  Optic atrophy following treatment with cobalt chloride in a patient with pancytopenia and hypercellular marrow. , 1972, Israel journal of medical sciences.

[48]  S. Hopfer,et al.  Cobalt, chromium, and nickel concentrations in body fluids of patients with porous‐coated knee or hip prostheses , 1989, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[49]  L. Walter,et al.  Distribution of chromium and cobalt ions in various blood fractions after resurfacing hip arthroplasty. , 2008, The Journal of arthroplasty.

[50]  C. Hess,et al.  Melatonin protects SHSY5Y neuroblastoma cells from cobalt‐induced oxidative stress, neurotoxicity and increased β‐amyloid secretion , 2001, Journal of pineal research.

[51]  Masashi Kobayashi,et al.  Inhibition of proteasome activity is involved in cobalt-induced apoptosis of human alveolar macrophages. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[52]  V. Carelli,et al.  Mitochondrial dysfunction as a cause of optic neuropathies , 2004, Progress in Retinal and Eye Research.

[53]  Boi Faltings,et al.  Sensing the Air We Breathe - The OpenSense Zurich Dataset , 2021, AAAI.

[54]  Sharad Kumar,et al.  Divalent metal transporter 1 (DMT1) regulation by Ndfip1 prevents metal toxicity in human neurons , 2009, Proceedings of the National Academy of Sciences.

[55]  G. Thomas,et al.  An analog of the human albumin N-terminus (Asp-Ala-His-Lys) prevents formation of copper-induced reactive oxygen species. , 2001, Biochemical and biophysical research communications.

[56]  P. Gros,et al.  Iron, manganese, and cobalt transport by Nramp1 (Slc11a1) and Nramp2 (Slc11a2) expressed at the plasma membrane. , 2003, Blood.

[57]  U. O. Schirrmacher Case of cobalt poisoning. , 1967, British medical journal.

[58]  J. H. Viles,et al.  Involvement of a lysine residue in the N-terminal Ni2+ and Cu2+ binding site of serum albumins. Comparison with Co2+, Cd2+ and Al3+. , 1994, European journal of biochemistry.

[59]  D. Back,et al.  How Do Serum Cobalt and Chromium Levels Change after Metal-on-Metal Hip Resurfacing? , 2005, Clinical orthopaedics and related research.

[60]  C. Heisel,et al.  Characterization of the running-in period in total hip resurfacing arthroplasty: an in vivo and in vitro metal ion analysis. , 2008, The Journal of bone and joint surgery. American volume.

[61]  P. Becker,et al.  Biological variation of ischaemia-modified albumin in healthy subjects , 2008, Cardiovascular journal of Africa.

[62]  Anna Ghelli,et al.  The Background of Mitochondrial DNA Haplogroup J Increases the Sensitivity of Leber's Hereditary Optic Neuropathy Cells to 2,5-Hexanedione Toxicity , 2009, PloS one.

[63]  G. Heinze,et al.  Long‐term follow‐up of metal‐on‐metal total hip replacement , 2007, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[64]  D. Murray,et al.  Serum levels of cobalt and chromium in a complex modular total hip arthroplasty system. , 2002, The Journal of arthroplasty.

[65]  A. Alimonti,et al.  The release of metals from metal-on-metal surface arthroplasty of the hip. , 2006, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.

[66]  H. W. Ruediger,et al.  Increased blood cobalt and chromium after total hip replacement. , 1999, Journal of toxicology. Clinical toxicology.

[67]  W. Steens,et al.  Severe cobalt poisoning with loss of sight after ceramic-metal pairing in a hip—a case report , 2006, Acta orthopaedica.

[68]  D. Milea,et al.  OPA1-associated disorders: phenotypes and pathophysiology. , 2009, The international journal of biochemistry & cell biology.

[69]  M. Demedts,et al.  Activation of the hexose monophosphate shunt in rat type II pneumocytes as an early marker of oxidative stress caused by cobalt particles , 2002, Archives of Toxicology.

[70]  Jiping Zeng,et al.  Involvement of caspase‐3 and p38 mitogen‐activated protein kinase in cobalt chloride‐induced apoptosis in PC12 cells , 2002, Journal of neuroscience research.

[71]  B. Diwan,et al.  Oxidative DNA base damage in renal, hepatic, and pulmonary chromatin of rats after intraperitoneal injection of cobalt(II) acetate. , 1994, Chemical research in toxicology.

[72]  W. Zou,et al.  Cobalt chloride induces PC12 cells apoptosis through reactive oxygen species and accompanied by AP‐1 activation , 2001, Journal of neuroscience research.

[73]  I. C. Smith,et al.  Osmium: An Appraisal of Environmental Exposure , 1974, Environmental health perspectives.

[74]  P. Spinelli,et al.  Exposure to cobalt and nickel in the hard-metal production industry , 1998, International archives of occupational and environmental health.

[75]  D. Johns,et al.  Smoking as an aetiological factor in a pedigree with Leber’s hereditary optic neuropathy , 1999, British Journal of Ophthalmology.

[76]  B. Gähwiler,et al.  Cobalt blocks postsynaptic responses induced by neurotransmitters in the hippocampus in vitro , 1991, Neuroscience Letters.

[77]  H. Rüdiger,et al.  INDUCTION OF 8-HYDROXY-2'-DEOXYGUANOSINE BY COBALT(II) AND HYDROGEN PEROXIDE IN VITRO , 2002, Journal of toxicology and environmental health. Part A.

[78]  M. Hasan,et al.  Cobalt-induced depletion of dopamine, norepinephrine & 5-hydroxytryptamine concentration in different regions of the rat brain. , 1980, Indian journal of experimental biology.

[79]  A. Forge,et al.  Differential vulnerability of basal and apical hair cells is based on intrinsic susceptibility to free radicals , 2001, Hearing Research.

[80]  K. Shitoto,et al.  Cobalt and chromium concentrations in patients with metal-on-metal and other cementless total hip arthroplasty , 2002, Archives of Orthopaedic and Trauma Surgery.

[81]  K. Yokota,et al.  Urinary elimination of nickel and cobalt in relation to airborne nickel and cobalt exposures in a battery plant , 2007, International archives of occupational and environmental health.

[82]  J. Ito,et al.  Role of reactive radicals in degeneration of the auditory system of mice following cisplatin treatment , 2004, Acta oto-laryngologica.

[83]  P. Campbell,et al.  Serum and urine metal levels in patients with metal-on-metal surface arthroplasty , 2002, Journal of materials science. Materials in medicine.

[84]  J. Rompen,et al.  Blind and deaf after total hip replacement? , 2009, The Lancet.

[85]  M. Valko,et al.  Free radicals, metals and antioxidants in oxidative stress-induced cancer. , 2006, Chemico-biological interactions.

[86]  T. Szekeres,et al.  Four‐year study of cobalt and chromium blood levels in patients managed with two different metal‐on‐metal total hip replacements , 2003, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[87]  B. Morrey Serum Metal Ion Exposure after Total Knee Arthroplasty , 2008 .

[88]  J. Domingo,et al.  Cobalt in the environment and its toxicological implications. , 1989, Reviews of environmental contamination and toxicology.

[89]  M. Demedts,et al.  Indices of oxidative stress in hamster lung following exposure to cobalt(II) ions: in vivo and in vitro studies. , 1991, American journal of respiratory cell and molecular biology.

[90]  G. Varela-Moreiras,et al.  Cobalamin, folic acid, and homocysteine. , 2009, Nutrition reviews.

[91]  E. Rubel,et al.  Electron microscopy of degenerative changes in the chick basilar papilla after gentamicin exposure , 2004, The Journal of comparative neurology.

[92]  R. Villar,et al.  Levels of metal ions after small- and large-diameter metal-on-metal hip arthroplasty. , 2003, The Journal of bone and joint surgery. British volume.

[93]  N. Denko,et al.  HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. , 2006, Cell metabolism.

[94]  J. P. Travers,et al.  Acute confusion and blindness from quinine toxicity. , 2003, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.

[95]  D. Lison CHAPTER 25 – Cobalt , 2007 .

[96]  P. Maxwell,et al.  HIF and oxygen sensing; as important to life as the air we breathe? , 2003, Annals of medicine.

[97]  Gunnar F. Nordberg,et al.  Handbook on the Toxicology of Metals , 1979 .

[98]  T. Mohammadian,et al.  The Comparative Study of Binding Characteristics of Cobalt and Iron to Human Serum Transferrin , 2004 .

[99]  T. Schmalzried,et al.  Progressive bilateral pelvic osteolysis in a patient with McKee-Farrar metal-metal total hip prostheses. , 1997, The Journal of arthroplasty.

[100]  P. Humphrey,et al.  Industrial exposure to cobalt causing optic atrophy and nerve deafness: a case report. , 1991, Journal of Neurology Neurosurgery & Psychiatry.

[101]  L. Rybak,et al.  Mechanisms of cisplatin-induced ototoxicity and prevention , 2007, Hearing Research.

[102]  P. Campbell,et al.  Metal ion levels in a triathlete with a metal-on-metal resurfacing arthroplasty of the hip. , 2007, The Journal of bone and joint surgery. British volume.

[103]  A. Sanz-Medel,et al.  High-resolution ICP–MS determination of Ti, V, Cr, Co, Ni, and Mo in human blood and urine of patients implanted with a hip or knee prosthesis , 2008, Analytical and bioanalytical chemistry.

[104]  M. Kuster,et al.  Massive wear of an incompatible metal-on-metal articulation in total hip arthroplasty. , 2004, The Journal of arthroplasty.

[105]  S. Tower Arthroprosthetic cobaltism: identification of the at-risk patient. , 2010, Alaska medicine.

[106]  F. Gardner The use of cobaltous chloride in the anemia associated with chronic renal disease. , 1953, The Journal of laboratory and clinical medicine.

[107]  Myriam Bernaudin,et al.  Hypoxic preconditioning protects against ischemic brain injury , 2011, NeuroRX.

[108]  C. Kufta,et al.  Feasibility of a visual prosthesis for the blind based on intracortical microstimulation of the visual cortex , 1996 .

[109]  M. Lavigne,et al.  Blood and urine metal ion levels in young and active patients after Birmingham hip resurfacing arthroplasty. , 2007, The Journal of bone and joint surgery. British volume.

[110]  G. Lippi,et al.  Potential value for new diagnostic markers in the early recognition of acute coronary syndromes. , 2006, CJEM.

[111]  P. Faller,et al.  Evidence that the principal CoII-binding site in human serum albumin is not at the N-terminus: implication on the albumin cobalt binding test for detecting myocardial ischemia. , 2007, Biochemistry.

[112]  K. Tomita,et al.  Polyneuropathy caused by cobalt–chromium metallosis after total hip replacement , 2010, Muscle & nerve.

[113]  G. Semenza,et al.  HIF-1 Regulates Cytochrome Oxidase Subunits to Optimize Efficiency of Respiration in Hypoxic Cells , 2007, Cell.

[114]  S. Himeno,et al.  The role of zinc transporters in cadmium and manganese transport in mammalian cells. , 2009, Biochimie.

[115]  D. Slone,et al.  The cobalt-albumin binding assay: insights into its mode of action. , 2008, Clinica chimica acta; international journal of clinical chemistry.

[116]  M. Manley,et al.  Metal-on-Metal total hip replacement: what does the literature say? , 2005, The Journal of arthroplasty.